Similar mechanism is found in ovarian cancer stem cells: Hypoxia-induced HIF-2α overexpression endows ovarian cancer stem cells with resistance to adriamycin by promoting BCRP expression and adriamycin efflux [139]. This evidence concerns the gene EPAS1 and ovarian carcinoma.